What does the future hold for robotics in medicine?
Medical experts from Weill Cornell Medicine discuss this fascinating topic. Joining us for this panel are Cheguevara Afaneh, MD; T. Sloane Guy, MD; Jim Hu, MD; Jeffrey Port, MD; Douglas Scherr, MD; and Joel Stein, MD, with moderator Dr. Max Gomez from WCBS-TV.
The past decade has produced tremendous advances in the use of robotics across clinical areas, vastly expanding the horizons of disease management.
Dr. Timothy McClure joined Brady Urology as a full time faculty member during the summer of 2016, providing his expertise to both the Departments of Urology & Radiology. Dr. McClure is an expert in imaging, image-guided therapy, and the minimally invasive treatment of urologic disease. Dr. McClure brings a unique training background to the department as he is not only a urologist, but also a board-certified radiologist who is fellowship trained in vascular and interventional radiology. Dr.
The LeFrak Center for Robotic Surgery is home to a partnership between the most technologically-advanced surgical robots and the most experienced and dedicated surgical team. The Center is led by the internationally renowned surgeon, Dr. Jim C.
Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.
Joseph J. Del Pizzo, M.D. is the E. Darracott Vaughan Jr., Professor of Urology and the Board Certified Director of Laparoscopic and Robotic Surgery for the Department of Urology at Weill Cornell Medicine. He joined the surgical staff at The New York Presbyterian Hospital in 2000 after serving as a clinical fellow in Laparoscopy and Minimally Invasive Urology.
Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy, as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology, I continually interact with colleagues in the areas of medical oncology, radiation oncology, and pathology, among others, in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer.
Dr. Jim Hu is a urologic oncologist with his undergraduate degree in Economics, his Master’s in Public Health in HealtPolicy and Management from Johns Hopkins University, and his Medical Degree from Baylor College of Medicine. He completed his Urology Residency at the David Geffen School of Medicine at UCLA and his Robotic Surgery/Urologic Oncology Fellowship in 2004 at City of Hope National Medical Center.